ArticleRheumatology and therapy2022

Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study.

Yanying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.